150 related articles for article (PubMed ID: 32814633)
1. Is thyroid cancer prognosis affected by solid organ transplantation?
Webb C; Cronin P; Gupta N; Verhey J; Calderon E; Moss A; Mathur AK; Pockaj B; Wasif N; Stucky CC
Surgery; 2021 Jan; 169(1):58-62. PubMed ID: 32814633
[TBL] [Abstract][Full Text] [Related]
2. De novo thyroid cancer following solid organ transplantation-A 25-year experience at a high-volume institution with a review of the literature.
Kluijfhout WP; Drake FT; Pasternak JD; Beninato T; Mitmaker EJ; Gosnell JE; Shen WT; Suh I; Freise CE; Duh QY
J Surg Oncol; 2017 Feb; 115(2):105-108. PubMed ID: 28054345
[TBL] [Abstract][Full Text] [Related]
3. Early postoperative stimulated serum thyroglobulin quantifies risk of recurrence in papillary thyroid cancer.
Jayasekara J; Jonker P; Lin JF; Engelsman AF; Wong MS; Kruijff S; Aniss A; Learoyd D; Bligh RC; Glover A; Delbridge L; Sidhu S; Sywak M
Surgery; 2020 Jan; 167(1):40-45. PubMed ID: 31515121
[TBL] [Abstract][Full Text] [Related]
4. Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.
Kelly A; Barres B; Kwiatkowski F; Batisse-Lignier M; Aubert B; Valla C; Somda F; Cachin F; Tauveron I; Maqdasy S
PLoS One; 2019; 14(8):e0221298. PubMed ID: 31425569
[TBL] [Abstract][Full Text] [Related]
5. Is thyroid cancer recurrence risk increased after transplantation?
Tisset H; Kamar N; Faugeron I; Roy P; Pouteil-Noble C; Klein M; Mourad G; Drui D; Do Cao C; Leenhardt L; Allix I; Bonichon F; Morelon E; Leboulleux S; Kelly A; Niccoli P; Toubert ME; Frimat L; Vantyghem MC; Bournaud C; Schlumberger M; Borson-Chazot F;
J Clin Endocrinol Metab; 2013 Oct; 98(10):3981-8. PubMed ID: 23884779
[TBL] [Abstract][Full Text] [Related]
6. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
7. Risk of Thyroid Cancer Among Solid Organ Transplant Recipients.
Kitahara CM; Yanik EL; Ladenson PW; Hernandez BY; Lynch CF; Pawlish KS; Engels EA
Am J Transplant; 2017 Nov; 17(11):2911-2921. PubMed ID: 28397388
[TBL] [Abstract][Full Text] [Related]
8. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
9. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
[TBL] [Abstract][Full Text] [Related]
10. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice.
Rubinstein JC; Herrick-Reynolds K; Dinauer C; Morotti R; Solomon D; Callender GG; Christison-Lagay ER
J Surg Res; 2020 May; 249():58-66. PubMed ID: 31923715
[TBL] [Abstract][Full Text] [Related]
11. Follicular thyroid cancer in children and adolescents: clinicopathologic features, long-term survival, and risk factors for recurrence.
Enomoto K; Enomoto Y; Uchino S; Yamashita H; Noguchi S
Endocr J; 2013; 60(5):629-35. PubMed ID: 23327804
[TBL] [Abstract][Full Text] [Related]
12. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
13. Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma?
Harries V; Wang LY; McGill M; Xu B; Tuttle RM; Wong RJ; Shaha AR; Shah JP; Ghossein R; Patel SG; Ganly I
Surgery; 2020 Jan; 167(1):10-17. PubMed ID: 31515125
[TBL] [Abstract][Full Text] [Related]
14. The extent of lymph node yield in central neck dissection can be affected by preoperative and intraoperative assessment and alter the prognosis of papillary thyroid carcinoma.
Hu JQ; Wen D; Ma B; Zhang TT; Liao T; Shi X; Wang YL; Zhu YX; Wang Y; Wei WJ; Ji QH
Cancer Med; 2020 Feb; 9(3):1017-1024. PubMed ID: 31854077
[TBL] [Abstract][Full Text] [Related]
15. No adverse affect in clinical outcome using low preablation diagnostic (131)i activity in differentiated thyroid cancer: refuting thyroid-stunning effect.
Yap BK; Murby B
J Clin Endocrinol Metab; 2014 Jul; 99(7):2433-40. PubMed ID: 24762114
[TBL] [Abstract][Full Text] [Related]
16. Death from thyroid cancer of follicular cell origin.
Wu HS; Young MT; Ituarte PH; D'Avanzo A; Duh QY; Greenspan FS; Loh KC; Clark OH
J Am Coll Surg; 2000 Dec; 191(6):600-6. PubMed ID: 11129807
[TBL] [Abstract][Full Text] [Related]
17. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
19. Differentiated Thyroid Cancer: The Role of ATA Nodal Risk Factors in N1b Patients.
Taboni S; Paderno A; Giordano D; Albano D; Piana S; Zanetti E; Bertagna F; Grammatica A; Ghidini A; Cappelli C; Bozzola A; Baronchelli C; Nicolai P; Lombardi D
Laryngoscope; 2021 Mar; 131(3):E1029-E1034. PubMed ID: 33319385
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]